Literature DB >> 22339545

Dietary D-psicose reduced visceral fat mass in high-fat diet-induced obese rats.

Young-Mee Chung1, Joo Hyun Lee, Deuk Youl Kim, Se-Hee Hwang, Young-Ho Hong, Seong-Bo Kim, Song Jin Lee, Chi Hye Park.   

Abstract

UNLABELLED: D-Psicose, a C-3 epimer of D-fructose, has shown promise in reducing body fat accumulation in normal rats and plasma glucose level in genetic diabetic mice. Effects of D-psicose on diet-induced obesity are not clearly elucidated, and we investigated food intake, body weight, and fat accumulation in rats fed high-fat (HF) diet. Sprague-Dawley rats became obese by feeding HF diet for 4 wk, and were assigned either to normal or HF diet supplemented with or without D-psicose, sucrose, or erythritol for 8 wk. Changing HF to normal diet gained less body weight and adipose tissue due to different energy intake. D-psicose-fed rats exhibited lower weight gain, food efficiency ratio, and fat accumulation than erythritol- and sucrose-fed rats. This effect was more prominent in D-psicose-fed rats with normal diet than with HF diet, suggesting combination of psicose and calorie restriction further reduced obesity. There was no difference in serum cholesterol/high-density lipoprotein (HDL)-C and low-density lipoprotein (LDL)-C/HDL-C ratios between D-psicose group and other groups. Liver weight in 5% psicose group with normal diet was higher than in other groups, but histopathological examination did not reveal any psicose-related change. D-Psicose inhibited the differentiation of mesenchymal stem cell (MSC) to adipose tissue in a concentration-dependent manner. These results demonstrate that D-psicose produces a marked decrease, greater than erythritol, in weight gain and visceral fat in an established obesity model by inhibiting MSC differentiation to adipocyte. Thus, D-psicose can be useful in preventing and reducing obesity as a sugar substitute and food ingredient. PRACTICAL APPLICATION: We can develop D-psicose as a sugar substitute and food ingredient since it can prevent obesity in normal people, but also suppress adiposity as a sugar substitute or food ingredients with antiobesity effect in obese people. D-psicose can be unique functional sweetener because of its function of reducing visceral fat mass and weight gain.
© 2012 Institute of Food Technologists®

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22339545     DOI: 10.1111/j.1750-3841.2011.02571.x

Source DB:  PubMed          Journal:  J Food Sci        ISSN: 0022-1147            Impact factor:   3.167


  12 in total

1.  A two-step strategy for the preparation of 6-deoxy-l-sorbose.

Authors:  Liuqing Wen; Kenneth Huang; Yuan Zheng; Yunpeng Liu; He Zhu; Peng George Wang
Journal:  Bioorg Med Chem Lett       Date:  2016-03-25       Impact factor: 2.823

2.  Glycolytic inhibition: an effective strategy for developing calorie restriction mimetics.

Authors:  Donald K Ingram; George S Roth
Journal:  Geroscience       Date:  2020-11-12       Impact factor: 7.713

3.  Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL/6 mice caused by chronic high-fat diet intake.

Authors:  Saritha Krishna; Zhoumeng Lin; Claire B de La Serre; John J Wagner; Donald H Harn; Lacey M Pepples; Dylan M Djani; Matthew T Weber; Leena Srivastava; Nikolay M Filipov
Journal:  Physiol Behav       Date:  2016-02-04

4.  Efficient enzymatic synthesis of L-rhamnulose and L-fuculose.

Authors:  Liuqing Wen; Lanlan Zang; Kenneth Huang; Shanshan Li; Runling Wang; Peng George Wang
Journal:  Bioorg Med Chem Lett       Date:  2015-12-17       Impact factor: 2.823

5.  Two-step enzymatic synthesis of 6-deoxy-L-psicose.

Authors:  Liuqing Wen; Kenneth Huang; Yuan Zheng; Junqiang Fang; Shukkoor Muhammed Kondengaden; Peng George Wang
Journal:  Tetrahedron Lett       Date:  2016-07-06       Impact factor: 2.415

6.  D-Allulose enhances uptake of HDL-cholesterol into rat's primary hepatocyte via SR-B1.

Authors:  Akane Kanasaki; Tetsuo Iida; Koji Murao; Bungo Shirouchi; Masao Sato
Journal:  Cytotechnology       Date:  2020-02-21       Impact factor: 2.058

7.  D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats.

Authors:  Wanpitak Pongkan; Kewarin Jinawong; Wasana Pratchayasakul; Thidarat Jaiwongkam; Sasiwan Kerdphoo; Masaaki Tokuda; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Eur J Nutr       Date:  2020-10-03       Impact factor: 5.614

8.  The long-term safety of D-allulose administration in healthy dogs.

Authors:  Naohito Nishii; Satoshi Takashima; Yui Kobatake; Masaaki Tokuda; Hitoshi Kitagawa
Journal:  J Vet Med Sci       Date:  2017-09-17       Impact factor: 1.267

9.  Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study.

Authors:  Francesco Franchi; Dmitry M Yaranov; Fabiana Rollini; Andrea Rivas; Jose Rivas Rios; Latonya Been; Yuma Tani; Masaaki Tokuda; Tetsuo Iida; Noriko Hayashi; Dominick J Angiolillo; Arshag D Mooradian
Journal:  BMJ Open Diabetes Res Care       Date:  2021-02

10.  Vanadium methyl-bipyridine organoligand and its influence on energy balance and organs mass.

Authors:  Mirosław Krośniak; Renata Francik; Agnieszka Wojtanowska-Krośniak; Cinzia Tedeschi; Małgorzata Krasoń-Nowak; Joanna Chłopicka; Ryszard Gryboś
Journal:  Biol Trace Elem Res       Date:  2014-09       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.